| Ansøgningsnr. og dato | 14704502.5 (espacenet) (Federated) (European Patent Register), 20140130 | | Patent/reg.nr. og dato | DK/EP 2950786, 20191127 | | Tilgængelighedsdato | 20151209 | | Prioritetsnr. og dato | US 201361759320 P, 20130131, US 201361772292 P, 20130304, US 201361828899 P, 20130530, US 201361870729 P, 20130827, US 201361897793 P, 20131030, US 201361907332 P, 20131121 | | EP publ. nr. og dato |
EP 2950786 20151209 | | Løbedag | | | Ansøger/indehaver | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City
CA 94404, US | | Ansøgers ref. nr. | P71091dk01 | | Opfinder | CHAL, Ben, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, California 94404, US,
MOGALIAN, Erik, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, California 94404, US,
PAKDAMAN, Rowchanak, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, California 94404, US,
OLIYAI, Reza, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, California 94404, US,
STEFANIDIS, Dimitrios, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, California 94404, US,
ZIA, Vahid, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, California 94404, US | | Fuldmægtig | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/381 (2006.01) , A61K 31/4025 (2006.01) , A61K 31/4184 (2006.01) , A61K 31/439 (2006.01) , A61K 31/4709 (2006.01) , A61K 31/497 (2006.01) , A61K 31/4985 (2006.01) , A61K 31/501 (2006.01) , A61K 31/5025 (2006.01) , A61K 31/513 (2006.01) , A61K 31/5377 (2006.01) , A61K 31/675 (2006.01) , A61K 31/7056 (2006.01) , A61K 31/7072 (2006.01) , A61K 31/7076 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61K 9/24 (2006.01) | | Titel/benævnelse | KOMBINATIONSFORMULERING AF TO ANTIVIRALE FORBINDELSER | | Internationalt ansøgningsnr. | US2014013953 | | Internationalt publ. nr. | WO2014120981 | | Relateret sag (certifikat) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
